Table 2. Results of multivariate Cox proportional-hazards analysis in testing set.
Variable | For death | For recurrence-free survival | ||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% confidence interval | p | Hazard Ratio | 95% confidence interval | p | |
Age <50.00 years (VS. ≥50years) | 0.558 | 0.297 to 1.050 | 0.07 | 0.558 | 0.297 to 1.047 | 0.069 |
Gender male (VS. female) | 0.774 | 0.263 to 2.276 | 0.642 | 0.752 | 0.255 to 2.215 | 0.605 |
Clinical stage IV+III (VS. II+I) | 3.467 | 1.197 to 10.037 | 0.022 | 3.289 | 1.136 to 9.527 | 0.028 |
Tumor size ≤5.0cm | 1.366 | 0.656 to 2.843 | 0.404 | 1.339 | 0.646 to 2.777 | 0.432 |
(VS.>5.0cm) | ||||||
AFP <200ng/mL (VS. ≥200ng/mL) | 1.149 | 0.514 to 2.573 | 0.735 | 1.127 | 0.504 to 2.520 | 0.771 |
Edmonson grade | 5.075 | 2.052 to 12.551 | 0 | 5.001 | 2.013 to 12.424 | 0.001 |
Low (vs.high) | ||||||
Tumor number solitary (vs. mutiple) | 1.072 | 0.539 to 2.134 | 0.842 | 10.6 | 0.534 to 2.106 | 0.867 |
USP22 Positive (vs. negative) | 4.973 | 2.115 to 11.693 | 0 | 4.943 | 2.100 to 11.636 | 0 |